ArticleAllergy, asthma & immunology research2018

The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs.

Heung Woo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.